⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Gershwin BlydenM.D.

Internal Medicine · Miami, FL 33138

NPI: 1851344014

Share:

34

🟠 Elevated

Risk Flags

Very high opioid rate vs specialty peersHigh cost outlier (population + peer)High long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

3,248

Total Claims

$2.5M

Drug Cost

224

Beneficiaries

$11K

Cost/Patient

Risk Score Breakdown 34/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+18
Long-acting opioid rate+8
Cost per patient outlier+6

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+985%

Opioid rate vs peers

24.3% vs 2.2% avg

+684%

Cost per patient vs peers

$11K vs $1,411 avg

+34%

Brand preference vs peers

14.3% vs 10.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 985% above the average for Internal Medicine providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

💰

Cost per patient is 684% above the specialty average. Extreme cost outliers may indicate prescribing of unnecessarily expensive brand-name drugs or inappropriate drug utilization.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

24.3%

Opioid Rate

789

Opioid Claims

$178K

Opioid Cost

32.1%

Long-Acting Rate

This provider's opioid prescribing rate of 24.3% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

86% generic

Brand: 462 claims · $2.1M

Generic: 2,772 claims · $370K

Patient Profile

66

Avg Age

56%

Female

3.10

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About